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Background: While continuous flow left-ventricular assist devices (CF-LVADs) represent a life-saving modality for patients with advanced heart 
failure (HF), data identifying common causes of readmission and the associated variable cost during the first year after implantation are lacking.
Methods: A descriptive analysis was conducted via retrospective review of patients implanted with a CF-LVAD at our institution between January 
1st, 2006 and August 2010. Electronic medical records and corporate data stores were reviewed to determine the primary ICD-9 code, duration and 
cause of readmission and the associated variable cost.
Results: A total of 74 CF-LVADs were implanted, 87.8 % (n= 65) survived to discharge and were included in our analysis. During study period, 
patients were censored at transplant and death. 68% male, mean age 54.2 +/- 11.28 years, 59% AA. Etiology of HF was 31.5 % ischemic. A total of 
190 readmissions with median length of stay (LOS) of 23 days (11-85) were observed. 75.8% (n=144) of the readmissions occurred within the 1st 
three months after implant. Overall, each patient had an average of 2.9 +/- 3.3 readmissions during the first year after implant, resulting in a mean 
annual variable cost of $24,800 +/- 31,400. Median LOS and variable cost associated with cause of readmission displayed below.
Table 1
Readmission N=190 Median LOS (range) Mean Total Variable Cost ($)
HF 40 6 (1-45) 11,400+/-11,300
Chest Pain 14 2 ( 1-9) 3,200+/-2,300
GI Bleed 12 4 (1-21) 6,500+/- 5,800
Dehydration 12 2 (1-6) 2,500-1,500
Conclusion: Significant cost is associated with readmisisons after CF-LVAD implantation. Further analysis of readmissions is warranted in order to 
identify preventable causes.
